Outbreak of hemolytic uremic syndrome with unusually severe clinical presentation caused by Shiga toxin-producing Escherichia coli O26:H11 in France

Hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli infection in Argentina: update of serotypes and genotypes and their relationship with severity of the disease

(2021) Laura F. Alconcher et al.   PEDIATRIC NEPHROLOGY

The emerging importance of Shiga toxin-producing Escherichia coli other than serogroup O157 in England

(2021) Bhavita Vishram et al.   JOURNAL OF MEDICAL MICROBIOLOGY

Shiga Toxin-Producing Escherichia coli Outbreaks in the United States, 2010–2017

(2021) Danielle M. Tack et al.   Microorganisms

Fluid restriction versus volume expansion in children with diarrhea-associated HUS: a retrospective observational study

(2020) Pablo Bonany et al.   PEDIATRIC NEPHROLOGY

Paediatric haemolytic uraemic syndrome related to Shiga toxin-producing Escherichia coli, an overview of 10 years of surveillance in France, 2007 to 2016

(2019) Mathias Bruyand et al.   Eurosurveillance

Outbreak of Shiga toxin-producing Escherichia coli (STEC) O26 paediatric haemolytic uraemic syndrome (HUS) cases associated with the consumption of soft raw cow’s milk cheeses, France, March to May 2019

(2019) Gabrielle Jones et al.   Eurosurveillance

Case-management protocol for bloody diarrhea as a model to reduce the clinical impact of Shiga toxin-producing Escherichia coli infections. Experience from Southern Italy

(2019) Daniela Loconsole et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Eculizumab treatment in severe pediatric STEC-HUS: a multicenter retrospective study

(2018) Lucas Percheron et al.   PEDIATRIC NEPHROLOGY

Emerging Shiga-toxin-producing Escherichia coli serogroup O80 associated hemolytic and uremic syndrome in France, 2013-2016: Differences with other serogroups

(2018) Brecht Ingelbeen et al.   PLoS One

Eculizumab in Typical Hemolytic Uremic Syndrome (HUS) With Neurological Involvement

(2015) Lars Pape et al.   MEDICINE

Prevalence of Carriage of Shiga Toxin-Producing Escherichia coli Serotypes O157:H7, O26:H11, O103:H2, O111:H8, and O145:H28 among Slaughtered Adult Cattle in France

(2014) Delphine Bibbal et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

Hemoconcentration: a major risk factor for neurological involvement in hemolytic uremic syndrome

(2014) Gianluigi Ardissino et al.   PEDIATRIC NEPHROLOGY

Hemolytic uremic syndrome

(2014) Caterina Mele et al.   Seminars in Immunopathology

An Outbreak of Shiga Toxin-Producing Escherichia coli O104:H4 Hemolytic Uremic Syndrome in Germany: Presentation and Short-term Outcome in Children

(2012) S. Loos et al.   CLINICAL INFECTIOUS DISEASES

Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic–uraemic syndrome: an analysis of the German STEC-HUS registry

(2012) Jan T. Kielstein et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study

(2012) J. Menne et al.   BMJ-British Medical Journal

Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial

(2011) Andreas Greinacher et al.   LANCET

Epidemic Profile of Shiga-Toxin–ProducingEscherichia coliO104:H4 Outbreak in Germany

(2011) Christina Frank et al.   NEW ENGLAND JOURNAL OF MEDICINE

Acute Neurological Involvement in Diarrhea-Associated Hemolytic Uremic Syndrome

(2010) S. Nathanson et al.   Clinical Journal of the American Society of Nephrology

Escherichia coli O157:H7: Animal Reservoir and Sources of Human Infection

(2010) Witold A. Ferens et al.   Foodborne Pathogens and Disease

Complement in Typical Hemolytic Uremic Syndrome

(2010) Dorothea Orth et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS